SHEILA MAYO: Open Payments
NPI 1366532145 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,396 in 54 payments from 10 companies in 2025. Trend: 2023 $2,665 · 2024 $1,754 · 2025 $1,396
Food & beverage: $1,324Education: $72
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $308 |
| Arcutis Biotherapeutics, Inc. | 15 | $270 |
| UCB, Inc. | 4 | $185 |
| Incyte Corporation | 5 | $171 |
| Novartis Pharmaceuticals Corporation | 4 | $168 |
| ABBVIE INC. | 5 | $117 |
| GENZYME CORPORATION | 2 | $70 |
| E.R. Squibb & Sons, L.L.C. | 3 | $61 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $31 |
| Amgen Inc. | 1 | $17 |
Products named: TREMFYA, Zoryve, Bimzelx, OPZELURA, COSENTYX, DUPIXENT, RINVOQ, Sotyktu.
Industry payments across CA — which companies pay providers there.
